Status:
RECRUITING
IV Fluids and Post-ERCP Pancreatitis
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
McGill University
University of Ottawa
Conditions:
ERCP
Eligibility:
All Genders
18+ years
Brief Summary
Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impract...
Detailed Description
1. Background and Rationale While very effective, endoscopic retrograde cholangiopancreatography (ERCP) is widely known to have the highest adverse event (AE) profile among all commonly performed ...
Eligibility Criteria
Inclusion
- Subject referred for ERCP, regardless of indication;
- Subject age 18 years or older;
- Subject able to give informed consent to involvement be included.
Exclusion
- Subject has a standard contraindication to ERCP;
- Subject or surrogate unable or unwilling to provide informed consent;
- Subject age \< 18 years.
Key Trial Info
Start Date :
January 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
13000 Patients enrolled
Trial Details
Trial ID
NCT05211206
Start Date
January 10 2022
End Date
February 28 2026
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peter Lougheed Hospital
Calgary, Alberta, Canada